Who owns GAIN THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Gain Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Gain Therapeutics stock

Who bought or sold GAIN THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Greenlight Capital 588k $1.9M 0% Dec 2023
 View chart
DME Capital Management 566k $2.1M 100% Mar 2024
 View chart
Raymond James & Associates 260k $980k 993% Mar 2024
 View chart
Royal Bank of Canada 249k $937k 24% Mar 2024
 View chart
Geode Capital Management 177k $668k 17% Mar 2024
 View chart
Vanguard Group 119k $450k 35% Mar 2024
 View chart
CM Management 90k $339k 0% Mar 2024
 View chart
BlackRock 75k $284k 170% Mar 2024
 View chart
Susquehanna International 73k $276k 12% Mar 2024
 View chart
Northern Trust 47k $175k 250% Mar 2024
 View chart
Millennium Management 44k $167k 248% Mar 2024
 View chart
Springbok Capital Management 36k $135k -38% Mar 2024
 View chart
Bridgeway Capital Management 30k $113k -35% Mar 2024
 View chart
Simplex Trading 18k $67k 100% Mar 2024
 View chart
Citadel Advisors 12k $47k -83% Mar 2024
 View chart
UBS Group 8.7k $33k -38% Mar 2024
 View chart
Tower Research Capital 4.6k $18k 61% Mar 2024
 View chart
Creekmur Asset Management 4.4k $17k 0% Mar 2024
 View chart
Wells Fargo & Company 3.8k $14k 1% Mar 2024
 View chart
Bank of America Corporation 3.4k $13k 100% Mar 2024
 View chart
Morgan Stanley 2.8k $11k 115% Mar 2024
 View chart
Group One Trading 2.0k $7.5k 3% Mar 2024
 View chart
Citigroup 684.00 $2.6k 100% Mar 2024
 View chart
Goss Wealth Management 225.00 $848.002500 -98% Mar 2024
 View chart

Who sold out of Gain Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Dimensional Fund Advisors Dec 2023 16k $52k
Advisor Group Holdings Dec 2023 10k $33k